Biospecimens Resource for Glomerular and Tubulo-interstitial Diseases


About this study

This study is being done to create a "resource" of samples that can be used to improve our ability to diagnose and treat MN, IgAN, MPGN, FSGS/MCD, Lupus Nephritis, AAV, other glomerular tubulo-interstitial disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosed with Membranous Nephropathy, IgA Nephropathy, Membranoproliferative Glomerulonephritis, Focal Segmental Glomerulosclerosis, Minimal Change Disease, Lupus Nephritis, Antineutrophil Cytoplasmic Antibody Associated Vasculitis, or Glomerular and tubulo-interstitial diseases.
  • Biologically related family members of accrued participants willing to provide genetic material for future studies.
  • Able to provide a blood sample.
  • Able to provide a urine sample.
  • Able to provide informed consent.
  • Age > 18 years or older.

Exclusion Criteria:

  • Age < 18 years or younger.
  • Unable to provide blood and/or urine sample.
  • Unable to provide consent without assistance.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Fernando Fervenza, M.D., Ph.D.

Open for enrollment

Contact information:

Gabrielle Hills

(507) 266-4616

More information


Publications are currently not available

Mayo Clinic Footer